Investegate | Company Announcement
Investegate announcements from PHAXIAM Provides Business and Financial Update for the Third Quarter of 2023
Source: investegate.co.uk
Pascal Birman News Today : Breaking News, Live Updates & Top Stories | Vimarsana
Stay updated with breaking news from Pascal Birman. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Top News In Pascal Birman Today - Breaking & Trending Today
PHAXIAM Therapeutics obtains authorizations to launch its phase 1 study in endocarditis infections caused by Staphylococcus aureus - PHAXIAM Therapeutics (NASDAQ:PHXM)
Approval of study design by French ANSM and Ethics Committee Recruitment of 12 patients expected to start in Q4 2023 in 4 French centersFirst study results expected in mid-2024 Lyon (France) et Cambridge (MA, US),
Source: benzinga.com
Investegate | Company Announcement
Investegate announcements from PHAXIAM Therapeutics obtains authorizations to launch its phase 1 study in endocarditis infections caused by Staphylococcus aureus
Source: investegate.co.uk
ERYTECH and PHERECYDES announce merger and name change to PHAXIAM Therapeutics
ERYTECH and PHERECYDES announce merger and name change to PHAXIAM Therapeutics Merger approved with large majority by the shareholders of both companiesNew governance structure implementedAmbition to create a global leader in extended phage therapies to ...
Source: marketscreener.com
Is Phage Therapy Ushering In A Post-Antibiotic Era
Faced with the emergence of resistant bacteria, phage therapy, which uses bacterial viruses (bacteriophages) to treat bacterial infections, is...
Source: pharmaceuticalonline.com